Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (41-50 of 173) with videos related to

Pageof 18
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer TherapiesFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
International Journal of Cancer|November 30, 2006
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signalingSandra Donnini, Martina Monti, Cinzia Castagnini, et al.
BMC Cancer|November 6, 2010
Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cellsMichele Navarra, Marilena Celano, Jessica Maiuolo, et al.
Journal of Medicinal Chemistry|October 16, 2009
New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoformsOlga Bruno, Alessia Romussi, Andrea Spallarossa, et al.
Bioorganic & Medicinal Chemistry|January 24, 2004
Synthesis and pharmacological evaluation of 5H-[1]benzopyrano[4,3-d]pyrimidines effective as antiplatelet/analgesic agentsOlga Bruno, Chiara Brullo, Silvia Schenone, et al.
Molecules (Basel, Switzerland)|November 19, 2020
Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-<i>d</i>]pyrimidines Kinase InhibitorsChiara Greco, Rosa Catania, Dario Leonardo Balacco, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2007
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxisOlga Bruno, Chiara Brullo, Francesco Bondavalli, et al.
Pharmaceutics|July 27, 2022
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma CellsLorenzo Monteleone, Barbara Marengo, Francesca Musumeci, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2006
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cellsAdriano Angelucci, Silvia Schenone, Giovanni Luca Gravina, et al.
Journal of Medicinal Chemistry|May 26, 2006
A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitorsFabrizio Manetti, Giada A Locatelli, Giovanni Maga, et al.
Pageof 18

Showing results (41-50 of 173) with videos related to

Sort By:
Pageof 18
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer TherapiesFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
International Journal of Cancer|November 30, 2006
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signalingSandra Donnini, Martina Monti, Cinzia Castagnini, et al.
BMC Cancer|November 6, 2010
Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cellsMichele Navarra, Marilena Celano, Jessica Maiuolo, et al.
Journal of Medicinal Chemistry|October 16, 2009
New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoformsOlga Bruno, Alessia Romussi, Andrea Spallarossa, et al.
Bioorganic & Medicinal Chemistry|January 24, 2004
Synthesis and pharmacological evaluation of 5H-[1]benzopyrano[4,3-d]pyrimidines effective as antiplatelet/analgesic agentsOlga Bruno, Chiara Brullo, Silvia Schenone, et al.
Molecules (Basel, Switzerland)|November 19, 2020
Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-<i>d</i>]pyrimidines Kinase InhibitorsChiara Greco, Rosa Catania, Dario Leonardo Balacco, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2007
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxisOlga Bruno, Chiara Brullo, Francesco Bondavalli, et al.
Pharmaceutics|July 27, 2022
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma CellsLorenzo Monteleone, Barbara Marengo, Francesca Musumeci, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2006
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cellsAdriano Angelucci, Silvia Schenone, Giovanni Luca Gravina, et al.
Journal of Medicinal Chemistry|May 26, 2006
A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitorsFabrizio Manetti, Giada A Locatelli, Giovanni Maga, et al.
Pageof 18